David Bussing is a Pharmaceutical Scientist currently pursuing a PhD in Pharmaceutical Science with a focus on pharmacokinetics and pharmacodynamics at the University at Buffalo. They served as an Advisor at Eli Lilly and Company since 2021 and previously conducted research as a Graduate Student Researcher at the University at Buffalo from 2015 to 2022. David's earlier experience includes roles as an Associate Professional at Allergan from 2012 to 2015 and as an intern in various capacities, including Research and Development at Thibiant International and Clinical Intern at Alamo Hills Medical Group. They hold a Bachelor of Science in Pharmacology from the University of California, Santa Barbara, where they studied from 2008 to 2012.
This person is not in the org chart
This person is not in any teams
This person is not in any offices